Total Payments
$4,585
2024 Payments
$94.81
Companies
29
Transactions
328
Medicare Patients
1,877
Medicare Billing
$274,255
Payment Breakdown by Category
Food & Beverage$4,404 (96.0%)
Education$181.35 (4.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,404 | 318 | 96.0% |
| Education | $181.35 | 10 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,230 | 60 | $0 (2024) |
| Novo Nordisk Inc | $972.50 | 80 | $0 (2022) |
| Lilly USA, LLC | $393.93 | 31 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $297.72 | 24 | $0 (2021) |
| PFIZER INC. | $288.78 | 21 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $227.52 | 19 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $142.78 | 11 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $138.46 | 11 | $0 (2021) |
| AbbVie Inc. | $135.56 | 16 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $106.06 | 10 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $94.81 | 6 | AstraZeneca Pharmaceuticals LP ($73.08) |
| 2023 | $57.45 | 4 | AstraZeneca Pharmaceuticals LP ($29.39) |
| 2022 | $261.15 | 13 | Novo Nordisk Inc ($153.21) |
| 2021 | $738.67 | 61 | Novo Nordisk Inc ($148.95) |
| 2020 | $833.18 | 58 | AstraZeneca Pharmaceuticals LP ($235.39) |
| 2019 | $896.93 | 57 | AstraZeneca Pharmaceuticals LP ($282.83) |
| 2018 | $686.93 | 59 | Novo Nordisk Inc ($140.09) |
| 2017 | $1,016 | 70 | AstraZeneca Pharmaceuticals LP ($336.50) |
All Payment Transactions
328 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Cardio-renal | ||||||
| 06/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Respiratory | ||||||
| 11/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/03/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Diabetes | ||||||
| 02/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Diabetes | ||||||
| 12/13/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Cardio-renal | ||||||
| 11/30/2022 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Neurology | ||||||
| 11/14/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Diabetes | ||||||
| 10/14/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: Obesity | ||||||
| 10/10/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 09/21/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: Obesity | ||||||
| 09/20/2022 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $116.00 | General |
| Category: Diabetes | ||||||
| 09/01/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Diabetes | ||||||
| 08/22/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: Diabetes | ||||||
| 08/22/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Education | In-kind items and services | $4.30 | General |
| Category: Diabetes | ||||||
| 07/28/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Diabetes | ||||||
| 02/10/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/12/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Education | In-kind items and services | $4.30 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 426 | 959 | $174,788 | $67,432 |
| 2022 | 4 | 522 | 1,116 | $149,347 | $76,995 |
| 2021 | 4 | 502 | 1,056 | $146,091 | $73,526 |
| 2020 | 6 | 427 | 1,027 | $134,710 | $56,302 |
Total Patients
1,877
Total Services
4,158
Medicare Billing
$274,255
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 264 | 763 | $128,410 | $46,899 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 119 | $24,425 | $11,640 | 47.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 53 | 53 | $17,575 | $7,565 | 43.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,331 | $1,187 | 35.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $1,047 | $142.01 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 270 | 808 | $98,326 | $40,827 | 41.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 124 | 124 | $18,600 | $18,231 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 167 | $27,904 | $16,431 | 58.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $4,517 | $1,506 | 33.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 258 | 725 | $88,225 | $36,471 | 41.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 150 | 237 | $39,600 | $24,234 | 61.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 58 | 58 | $8,700 | $8,648 | 99.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $9,566 | $4,173 | 43.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 234 | 740 | $90,051 | $30,697 | 34.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 85 | 124 | $20,719 | $9,944 | 48.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 52 | 52 | $7,800 | $6,779 | 86.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 31 | 76 | $8,639 | $4,738 | 54.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 12 | $3,752 | $2,075 | 55.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 13 | 23 | $3,749 | $2,069 | 55.2% |
About Dr. Barbara Etheridge, M.D
Dr. Barbara Etheridge, M.D is a Family Medicine healthcare provider based in Somerset, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184792814.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Etheridge, M.D has received a total of $4,585 in payments from pharmaceutical and medical device companies, with $94.81 received in 2024. These payments were reported across 328 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,404).
As a Medicare-enrolled provider, Etheridge has provided services to 1,877 Medicare beneficiaries, totaling 4,158 services with total Medicare billing of $274,255. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Somerset, NJ
- Active Since 12/01/2006
- Last Updated 01/25/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184792814
Products in Payments
- FARXIGA (Drug) $1,022
- Ozempic (Drug) $457.85
- JANUVIA (Drug) $223.16
- TRULICITY (Drug) $214.20
- Saxenda (Drug) $182.86
- Trintellix (Drug) $162.69
- XARELTO (Drug) $159.50
- Victoza (Drug) $153.65
- CHANTIX (Drug) $126.69
- JARDIANCE (Drug) $97.92
- Belviq (Drug) $92.51
- BASAGLAR (Drug) $82.38
- UBRELVY (Drug) $81.95
- ASMANEX (Drug) $64.00
- INVOKANA (Drug) $62.00
- MOUNJARO (Drug) $58.13
- Vascepa (Drug) $55.24
- COLOGUARD (Device) $54.88
- VRAYLAR (Drug) $53.61
- SOLIQUA 100/33 (Biological) $52.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Somerset
Dr. Robert Drake, Md, MD
Family Medicine — Payments: $14,200
Family Medicine $14,200
Jeffrey Vanmeter, M.d, M.D
Family Medicine — Payments: $14,143
Family Medicine $14,143
Dr. Marlo Marcheleovich, D.o, D.O
Family Medicine — Payments: $9,217
Family Medicine $9,217
Lana New
Family Medicine — Payments: $8,316
Family Medicine $8,316
Christopher Lebo, D.o, D.O
Family Medicine — Payments: $7,165
Family Medicine $7,165
John Brennan, Md, MD
Family Medicine — Payments: $4,051
Family Medicine $4,051